Medical Weight Loss Clinic . Medical Weight Loss Clinic is administered by Michigan/Ohio Board Certified Physicians who are dedicated to helping you achieve your weight loss goals and maintain a healthy weight. Your custom weight loss plan is a phone call away. Medical Weight Loss Clinic has helped hundreds of thousands of people*Most diet plans claim to be customized because they split men and women up into two different categories. That’s not good enough – your body and your relationship with food, is unique. Once we have completed a medical history including your body composition analysis, we want to understand your goals. Then we select one of our programs and tailor it for your specific needs. Click here to learn more about our programs. Maria lost 5. 0 lbs in 1. Success Stories. Take a look at these success stories of people who have changed their lives with Medical Weight Loss Clinic. They are not the celebrities you see elsewhere, they don’t have a personal trainer or a chef, but they are our Superstars! They are people like you - Midwesterners who face the same struggles and challenges in life. Real people, who overcame real problems - an inspiration to us all. See our success stories* Results may vary. When you enroll in a Medical Weight Loss Clinic program, the length of your program will be determined by you and the staff based on the amount of weight you want to lose and how quickly you want to lose it. Your actual weight loss will be determined by many factors, including, but not limited to: your medical circumstances, the plan you choose, adherence to the meal plan and use of nutritional supplements. Your goal and program duration information will be given to you in writing at the time of enrollment. As your program progresses, the rate you lose weight may change and you will have the opportunity to discuss this at every daily visit with your weight loss consultant, where changes to your meal plan and/or program can be made. Depression - Healing. Well. com Forum. Select A Location****** Top of the Forum ******==== General Information ====Announcements. Frequently Asked Questions. Forum Rules & Guidelines==== Diseases & Conditions ====Allergies & Asthma. Alzheimer's Disease. Anxiety - Panic Disorders. Bipolar Disorder. Breast Cancer. Celiac Disease. Chronic Fatigue Syndrome. Chronic Pain. Crohn's Disease. Cystic Fibrosis. Depression. Diabetes. Epilepsy. Fibromyalgia. GERD - Heartburn. Heart & Cardiovascular Disease. Hepatitis. Irritable Bowel Syndrome. My depression lead to a 30lb weight loss. Weight Gain: Causes & Influential Factors. Antidepressants can cause unpleasant side effects. Symptoms such as nausea, weight gain or sleep problems can be common initially. For many people, these improve. Kidney Diseases & Disorders. Lupus. Lyme Disease. Migraine - Headache. Multiple Sclerosis. Osteoarthritis. Ostomies. Parkinson's Disease.
Prostate Cancer. Psoriasis. Rheumatoid Arthritis. Sjogren's Syndrome. Thyroid Disorders. Ulcerative Colitis. For those days you’re craving dessert for lunch, partake in this treat as part of the clinically- proven Slim. Common Side Effects of Prozac (Fluoxetine Hcl) Drug Center. SIDE EFFECTSThe following adverse reactions are discussed in more detail in other sections of the labeling: When using PROZAC and olanzapine in combination, also refer to the Adverse Reactions section of the package insert for Symbyax. Clinical Trials Experience. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect or predict the rates observed in practice. Multiple doses of PROZAC have been administered to 1. US clinical trials. In addition, there have been 4. PROZAC in panic clinical trials. The stated frequencies represent the proportion of individuals who experienced, at least once, a treatment- emergent adverse reaction of the type listed. A reaction was considered treatment- emergent if it occurred for the first time or worsened while receiving therapy following baseline evaluation. Incidence In Major Depressive Disorder, OCD, Bulimia, And Panic Disorder Placebo- Controlled Clinical Trials (Excluding Data From Extensions Of Trials) Table 3 enumerates the most common treatment- emergent adverse reactions associated with the use of PROZAC (incidence of at least 5% for PROZAC and at least twice that for placebo within at least 1 of the indications) for the treatment of Major Depressive Disorder, OCD, and bulimia in US controlled clinical trials and Panic Disorder in US plus non- US controlled trials. Table 5 enumerates treatment- emergent adverse reactions that occurred in 2% or more patients treated with PROZAC and with incidence greater than placebo who participated in US Major Depressive Disorder, OCD, and bulimia controlled clinical trials and US plus non- US Panic Disorder controlled clinical trials. Table 4 provides combined data for the pool of studies that are provided separately by indication in Table 3. Table 3: Most Common Treatment- Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo- Controlled Clinical Trials. Percentage of Patients Reporting Event Major Depressive Disorder. OCDBulimia. Panic Disorder. Body System/ Adverse Reaction. PROZAC (N=1. 72. 8)Placebo (N=9. PROZAC (N=2. 66)Placebo (N=8. PROZAC (N=4. 50)Placebo (N=2. PROZAC (N=4. 25)Placebo (N=3. Body as a Whole Asthenia. Flu syndrome. 34. Cardiovascular System Vasodilatation. Digestive. System Nausea. Diarrhea. 12. 81. Anorexia. 11. 21. Dry mouth. 10. 71. Dyspepsia. 75. 10. Nervous System Insomnia. Anxiety. 12. 71. 47. Nervousness. 14. 91. Somnolence. 13. 61. Tremor. 10. 39. 11. Libido decreased. Abnormal dreams. 11. Respiratory System Pharyngitis. Sinusitis. 14. 52. Yawn- -7- 1. 1- 1- Skinand Appendages Sweating. Rash. 43. 63. 44. Urogenital System Impotence. Abnormal. ejaculation. Incidence less than 1%. Includes US data for Major Depressive Disorder, OCD, Bulimia, and Panic Disorder clinical trials, plus non- US data for Panic Disorder clinical trials. Denominator used was for males only (N=6. PROZAC Major Depressive Disorder; N=4. Major Depressive Disorder; N=1. PROZAC OCD; N=4. 3 placebo OCD; N=1. PROZAC bulimia; N=1 placebo bulimia; N=1. PROZAC panic; N=1. Table 4: Treatment- Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo- Controlled Clinical Trials. Body System / Adverse Reaction. Percentage of Patients Reporting Event. Major Depressive Disorder, OCD, Bulimia,and Panic Disorder Combined. PROZAC (N=2. 86. 9)Placebo (N=1. Body as a Whole Headache. Asthenia. 11. 6 Flu syndrome. Fever. 21. Cardiovascular System Vasodilatation. Digestive System Nausea. Diarrhea. 11. 7 Anorexia. Dry mouth. 96 Dyspepsia. Constipation. 54 Flatulence. Vomiting. 32. Metabolic and Nutritional Disorders Weight loss. Nervous System Insomnia. Nervousness. 13. 8 Anxiety. Somnolence. 12. 5 Dizziness. Tremor. 92 Libido decreased. Thinking abnormal. Respiratory System Yawn. Skinand Appendages Sweating. Rash. 43 Pruritus. Special Senses Abnormal vision. Incidence less than 1%. Includes US data for Major Depressive Disorder, OCD, Bulimia, and Panic Disorder clinical trials, plus non- US data for Panic Disorder clinical trials. Associated With Discontinuation In Major Depressive Disorder, OCD, Bulimia, And Panic Disorder Placebo- Controlled Clinical Trials (Excluding Data From Extensions Of. Trials) Table 5 lists the adverse reactions associated with discontinuation of PROZAC treatment (incidence at least twice that for placebo and at least 1% for PROZAC in clinical trials collecting only a primary reaction associated with discontinuation) in Major Depressive Disorder, OCD, bulimia, and Panic Disorder clinical trials, plus non- US Panic Disorder clinical trials. Table 5: Most Common Adverse Reactions Associated with Discontinuation in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo- Controlled Clinical Trials. Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Combined (N=1. Major Depressive Disorder (N=3. OCD (N=2. 66)Bulimia (N=4. Panic Disorder (N=4. Anxiety (1%)- Anxiety (2%)- Anxiety (2%)- -- Insomnia (2%)- -Nervousness (1%)- -Nervousness (1%)- -Rash(1%)- -1. Includes US Major Depressive Disorder, OCD, Bulimia, and Panic Disorder clinical trials, plus non- US Panic Disorder clinical trials. Other Adverse Reactions In Pediatric Patients (Children And Adolescents)Treatment- emergent adverse reactions were collected in 3. The overall profile of adverse reactions was generally similar to that seen in adult studies, as shown in Tables 4 and 5. However, the following adverse reactions (excluding those which appear in the body or footnotes of Tables 4 and 5 and those for which the COSTART terms were uninformative or misleading) were reported at an incidence of at least 2% for fluoxetine and greater than placebo: thirst, hyperkinesia, agitation, personality disorder, epistaxis, urinary frequency, and menorrhagia. The most common adverse reaction (incidence at least 1% for fluoxetine and greater than placebo) associated with discontinuation in 3 pediatric placebo- controlled trials (N=4. In these clinical trials, only a primary reaction associated with discontinuation was collected. Reactions Observed In PROZAC Weekly Clinical Trials. Treatment- emergent adverse reactions in clinical trials with PROZAC Weekly were similar to the adverse reactions reported by patients in clinical trials with PROZAC daily. In a placebo- controlled clinical trial, more patients taking PROZAC Weekly reported diarrhea than patients taking placebo (1. PROZAC 2. 0 mg daily (1. Male And Female Sexual Dysfunction With SSRIs. Although changes in sexual desire, sexual performance, and sexual satisfaction often occur as manifestations of a psychiatric disorder, they may also be a consequence of pharmacologic treatment. In particular, some evidence suggests that SSRIs can cause such untoward sexual experiences. Reliable estimates of the incidence and severity of untoward experiences involving sexual desire, performance, and satisfaction are difficult to obtain, however, in part because patients and physicians may be reluctant to discuss them. Accordingly, estimates of the incidence of untoward sexual experience and performance, cited in product labeling, are likely to underestimate their actual incidence. In patients enrolled in US Major Depressive Disorder, OCD, and bulimia placebo- controlled clinical trials, decreased libido was the only sexual side effect reported by at least 2% of patients taking fluoxetine (4% fluoxetine, < 1% placebo). There have been spontaneous reports in women taking fluoxetine of orgasmic dysfunction, including anorgasmia. There are no adequate and well- controlled studies examining sexual dysfunction with fluoxetine treatment. Symptoms of sexual dysfunction occasionally persist after discontinuation of fluoxetine treatment. Priapism has been reported with all SSRIs. While it is difficult to know the precise risk of sexual dysfunction associated with the use of SSRIs, physicians. Other Reactions. Following is a list of treatment- emergent adverse reactions reported by patients treated with fluoxetine in clinical trials. This listing is not intended to include reactions (1) already listed in previous tables or elsewhere in labeling, (2) for which a drug cause was remote, (3) which were so general as to be uninformative, (4) which were not considered to have significant clinical implications, or (5) which occurred at a rate equal to or less than placebo. Reactions are classified by body system using the following definitions: frequent adverse reactions are those occurring in at least 1/1. Body As A Whole Frequent: chills; Infrequent: suicide attempt; Rare: acute abdominal syndrome. Cardiovascular System. Frequent: palpitation; Infrequent: arrhythmia, hypotension. Digestive System. Infrequent: dysphagia, gastritis, gastroenteritis, melena, stomach ulcer; Rare: bloody diarrhea, duodenal ulcer, esophageal ulcer, gastrointestinalhemorrhage, hematemesis, hepatitis, peptic ulcer, stomach ulcer hemorrhage. Hemic And Lymphatic System Infrequent: ecchymosis; Rare: petechia, purpura. Nervous System. Frequent: emotional lability; Infrequent: akathisia, ataxia, balance disorder. Rare: delusions. Respiratory System. Rare: larynx edema. Skin And Appendages. Infrequent: alopecia; Rare: purpuric rash. Special Senses. Frequent: taste perversion; Infrequent: mydriasis. Urogenital System. Frequent: micturition disorder; Infrequent: dysuria, gynecological bleeding. Med. DRA dictionary term from integrated database of placebo controlled trials of 1. Group term that includes individual Med. DRA terms: cervix hemorrhage uterine, dysfunctional uterine bleeding, genital hemorrhage, menometrorrhagia, menorrhagia, metrorrhagia, polymenorrhea, postmenopausal hemorrhage, uterine hemorrhage, vaginal hemorrhage. Adjusted for gender.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
May 2017
Categories |